Skip to main content
Drug Development Support

Preclinical Mouse Model Services

Since 1998, ingenious targeting laboratory has provided comprehensive preclinical support extending from custom model generation through in vivo studies and phenotyping. Our integrated approach enables seamless progression from model design to actionable preclinical data, eliminating handoffs between multiple service providers.

Whether you need standalone preclinical studies or end to end support from model conception through data delivery, ingenious targeting laboratory offers the scientific expertise and operational infrastructure to advance your drug development program.

2,500+
Projects Completed
800+
Publications
26+
Years Experience
100%
Success Rate

In Vivo Efficacy Studies

Efficacy studies evaluate therapeutic candidates in disease relevant mouse models. ingenious targeting laboratory designs and executes studies using your custom models or established disease models appropriate for your therapeutic target.

Study Design

Rigorous study design is essential for generating reliable preclinical data. Our team works with you to define:

  • Appropriate endpoints based on therapeutic hypothesis
  • Statistically powered group sizes
  • Optimized dosing regimens
  • Regulatory aligned analysis plans

Oncology Studies

Tumor efficacy studies evaluate antitumor activity using:

  • Syngeneic tumor models
  • Xenograft models
  • Genetically engineered tumor models
  • Tumor volume and survival endpoints
  • Correlative biomarker analysis
Oncology Models

Disease Model Studies

Therapeutic areas including neuroscience, metabolic disease, immunology, and cardiovascular research benefit from disease specific efficacy models. We design studies with endpoints relevant to your disease area and therapeutic approach.

Phenotyping Services

Phenotyping characterizes your mouse model across multiple parameters to understand the biological consequences of genetic modification. Comprehensive phenotyping informs experimental design and identifies unexpected phenotypes.

Basic Phenotyping

Foundational characterization identifies overt phenotypes and overall health impacts:

  • Body Weight Monitoring:Tracks growth curves and identifies developmental abnormalities
  • Survival Analysis:Enables Kaplan Meier analysis of lifespan effects
  • Gross Anatomy:Necropsy with organ weight measurement
  • Clinical Observations:Behavioral changes and neurological signs

Clinical Chemistry and Hematology

Blood based analysis provides insight into:

  • Metabolic, hepatic, renal, and hematopoietic function
  • Standard panels customized based on research focus
  • Blood based insight into model physiology

Histopathology

Tissue collection and histological analysis reveals structural changes at the cellular level. Board certified pathologists provide expert interpretation of findings.

Metabolic

Glucose tolerance testing for metabolic models

Cardiovascular

Echocardiography for cardiac models

Behavioral

Behavioral testing for neuroscience models

Immune

Immune phenotyping for immunology models

Pharmacology Studies

Pharmacology studies evaluate drug pharmacokinetics, pharmacodynamics, and target engagement in your mouse models.

PK Studies

Pharmacokinetic studies determine drug absorption, distribution, metabolism, and excretion. Time course sampling enables characterization of exposure profiles.

PD Studies

Pharmacodynamic studies correlate drug exposure with biological effect. Target engagement, biomarker modulation, and downstream pathway effects demonstrate mechanism of action.

PK/PD Modeling

Integration of pharmacokinetic and pharmacodynamic data enables modeling of exposure response relationships to guide dose selection.

Integrated Preclinical Programs

Model to Data

ingenious targeting laboratory's integrated capabilities enable seamless progression from custom model generation through breeding, cohort development, and preclinical studies. This eliminates the complexity and delays associated with transferring animals between service providers.

Study Coordination

Our project management team coordinates all aspects of preclinical programs, from initial model design through data delivery. Regular updates keep you informed of progress and enable adaptive study design.

Data Delivery

Preclinical study reports include complete methodology, raw data, statistical analysis, and interpretation. Data packages are formatted to support regulatory submissions and publication.

Quality and Compliance

AAALAC Accreditation

ingenious targeting laboratory operates AAALAC accredited facilities meeting the highest standards for animal care and welfare.

Regulatory Alignment

Study designs and documentation are prepared with regulatory requirements in mind, supporting IND enabling studies and other regulatory submissions.

✦ New for 2026

Breeding Scheme Architect

Plan complex multi-allele breeding strategies, calculate expected genotype ratios, and estimate time to experimental cohorts—all before starting your project.

Visualize multi-generation breeding paths
Calculate Mendelian ratios automatically
Estimate timeline to study ready cohorts

Free Research Tool

No account required

Allele 1Gene-flox (conditional)
Allele 2Cre-driver (tissue-specific)
TargetHomozygous knockout

→ 3 generations to target genotype

What Researchers Say

The Hephaestin flox model ingenious has made for us has been great. It has helped generate eight research publications.

Joshua Dunaief, PhD, MD

University of Pennsylvania

Start Your Project

Ready to discuss preclinical services for your program? Our scientific team provides complimentary consultation to help you design an integrated approach from model generation through preclinical data.

Frequently Asked Questions

GLP (Good Laboratory Practice) studies follow strict regulatory guidelines for documentation, quality control, and data integrity required for FDA submissions. Non-GLP studies provide exploratory data for research decisions and are more flexible in design and documentation. Most early-stage studies are non-GLP.

Services include efficacy testing (therapeutic response), PK/PD studies (pharmacokinetics and pharmacodynamics), safety/toxicology assessments, biomarker discovery, and combination therapy studies. Studies are customized based on your therapeutic program and regulatory requirements.

Yes. We can work with models you've already generated or models generated by ingenious targeting laboratory. Studies can be designed using your established colonies or we can manage colony expansion and breeding as part of the service package.

All studies include comprehensive reports with methods, results, statistical analysis, and interpretation. Data tables, figures, and raw data files are provided. For regulatory studies, documentation meets GLP standards. Study reports can support IND submissions and regulatory filings.

Lab Signals

Preclinical Services Insights

Expert research insights delivered biweekly. Written by PhD scientists, designed for researchers who need cutting-edge knowledge to advance their projects.

Subscribe Free